NCT04322266View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 21, 2018

Primary Completion Date

February 13, 2019

Study Completion Date

February 13, 2019

Conditions
Healthy
Interventions
DRUG

HCP1701

Ezetimibe / Rosuvastatin / Amlodipine / Losartan potassium

DRUG

HCP1306

Ezetimibe /Rosuvastatin

DRUG

HGP0904

Amlodipine

DRUG

HGP0608

Losartan potassium

Trial Locations (1)

Unknown

Korea University Hospital (Anam), Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT04322266 - A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. | Biotech Hunter | Biotech Hunter